Back to search

Article

Kinetic modeling of ImmunoPET enables in vivo quantification of EGFRvIII expression in glioblastoma

2026-04-20

Abstract excerpt

<title>Abstract</title> <p>Glioblastoma (GBM) remains the most lethal primary brain tumour in adults. Targeted strategies against epidermal growth factor receptor variant III (EGFRvIII), a tumour-specific mutation expressed in GBM, are advancing clinically; however, their success depends on accurate, non-invasive assessment of EGFRvIII-expression for patient selection. Here, we develop and validate an immuno-Posi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
338bf7b5-cf7a-5377-b4ea-6a9016db99e2
DOI
10.21203/rs.3.rs-9177895/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Kinetic modeling of ImmunoPET enables in vivo quantification of EGFRvIII expression in glioblastomaDOI 10.21203/rs.3.rs-9177895/v1
Select a neighboring publication to make it the new centre.